Bai-rong Xia
Clinical trials sponsored by Bai-rong Xia, explained in plain language.
-
Could a common heart drug boost ovarian cancer treatment?
Disease control Recruiting nowThis phase 2 trial tests whether adding propranolol, a widely used beta-blocker, to standard chemotherapy before surgery can improve outcomes for women with advanced high-grade serous ovarian cancer. Participants receive propranolol pills alongside paclitaxel and carboplatin, fol…
Phase: PHASE2 • Sponsor: Bai-Rong Xia • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Triple-Drug cocktail aims to boost ovarian cancer surgery success
Disease control Recruiting nowThis phase 2 trial is testing a combination of three drugs—ipalotinib, sunitinib, and olaparib—given before surgery to people with a specific type of advanced ovarian cancer (HRD-positive). The goal is to shrink tumors enough to allow complete removal during surgery. The study wi…
Phase: PHASE2 • Sponsor: Bai-Rong Xia • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC